This inventor holds 1 USPTO granted patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988
Title: Takafuni Fujioka: Innovator in Antihistamic Agents
Introduction
Takafuni Fujioka is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of carbostyril derivatives. His work focuses on creating compounds that exhibit antihistamic and central nervous controlling actions.
Latest Patents
Takafuni Fujioka holds a patent for "Pharmaceutically useful carbostyril derivatives." This patent describes carbostyril derivatives that are effective as antihistamic agents or central nervous controlling agents. The derivatives are represented by a complex general formula, which includes various substituents that enhance their pharmacological properties. He has 1 patent to his name.
Career Highlights
Fujioka is associated with Otsuka Pharmaceutical Company, Limited, where he continues to innovate in the pharmaceutical sector. His research has contributed to advancements in medications that target allergic reactions and central nervous system disorders.
Collaborations
Throughout his career, Takafuni Fujioka has collaborated with esteemed colleagues such as Kazuo Banno and Kazuyuki Nakagawa. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical agents.
Conclusion
Takafuni Fujioka's work in developing carbostyril derivatives showcases his commitment to advancing pharmaceutical science. His contributions are vital in the ongoing quest for effective antihistamic treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
